media – Page 621 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

New findings explain how UV rays trigger skin cancer

Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknown - until now.
- Source: Medicalxpress
- 568
- October 19, 2017
Melanoma
AstraZeneca admits cancer data for acquired drug was fabricated

AstraZeneca has revealed that early-stage data concerning the efficacy of its acquired drug acalabrutinib in the treatment of blood cancers and solid tumours was invented and falsified.
- Source: Pharmafile
- 638
- October 19, 2017
acalabrutinib AstraZeneca blood cancer solid tumour
Takeda and HemoShear Therapeutics Enter into Exclusive Drug Discovery Partnership in Liver Diseases

Takeda Pharmaceutical Company Limited and HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced a partnership to discover and develop novel therapeutics for liver diseases, including nonalcoholic steatohepatitis (NASH).
- Source: finance.yahoo
- 442
- October 18, 2017
Company Insight NASH therapeutics
Blood sugar pill shows promise

The pill form of the drug semaglutide is worth pursuing as a way to control blood sugar in patients with type 2 diabetes, say researchers.
- Source: medicalnewstoday
- 587
- October 18, 2017
diabetes glycemic Phase Researches semaglutide
Can an Asthma Drug Help Treat Parkinson’s Disease?

A recent study investigates the ability of an asthma drug to reduce levels of α-synuclein, a protein believed to contribute to the development of Parkinson’s disease.
- Source: medicalnewsbulletin
- 620
- October 18, 2017
asthma disorder Parkinson Researches
Neurotech International bags $4M to commercialise autism device

Neurotech International Ltd has successfully raised $4 million via a placement of shares at $0.20 each to drive its ongoing commercialisation of the Mente Autism device.
- Source: proactiveinvestors
- 668
- October 18, 2017
ASD autism Company Insight EEG medical device
A Significant Global Problem

A study of the global prevalence of fetal alcohol spectrum disorder (FASD) estimates that it affects as many as 8 out of 10,000 children, highlighting the need to improve public education about the potential harm of drinking alcohol during pregnancy.
- Source: medicalnewsbulletin
- 517
- October 18, 2017
alcohol FASD fetus Market Views
AstraZeneca’s Imfinzi gets speedy US review for lung cancer

US regulators have accepted an application by AstraZeneca and MedImmune to expand the scope of Imfinzi (durvalumab) to include patients with a certain form of lung cancer.
- Source: Pharmatimes
- 789
- October 18, 2017
AstraZeneca FDA Imfinzi (durvalumab) lung cancer
Medical Monitoring Device Maker MagicMed Bags USD1.5 Million in Pre-Series A Financing

Medical equipment maker MagicMed Technologies (Beijing) Co. has secured USD1.5 million (CNY10 million) in pre-series A financing. The funds will help the firm hasten the commercialization of its Magitor Cell, a single channel electrocardiographic monitoring device.
- Source: Yicaiglobal
- 416
- October 18, 2017
MagicMed Technologies Magitor Cell Series
AI could bring £630bn to UK by 2035

The review, led by Jerome Pesenti, chief executive of BenevolentTech and Dame Wendy Hall, Professor of Computer Science at the University of Southampton, says AI is expected to make “great improvements” for the public, including more personalised services, better healthcare and more efficient use of resources.
- Source: Pharmatimes
- 480
- October 17, 2017
Artificial Intelligence Industrial Strategy

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.